CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Outlines Parameters for Upcoming Research Designed to Study Effectiveness of THC-V in Weight Loss

July 30, 2020 11:28:53

Cannabis Global (OTC: MCTC), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, recently updated its shareholders regarding selected protocols for its planned animal study. MCTC will conduct research focused on determining if the administration of rare cannabinoid Tetrahydrocannabivarin (THC-V) promotes appetite suppression and/or weight loss in diet-induced obese mice. “This study is a first step to investigate if THC-V is, in fact, a weight loss or appetite suppressant,” said Cannabis Global CEO Arman Tabatabaei in a press release. “While the popular and industry press widely outlines THC-V as such, scientific research is severely lacking. We plan to take the industry a step forward relative to THC-V via this study. We also hope to shed some light on the potential effectiveness of our highly loaded nanoparticles of manufactured THC-V versus the botanically derived cannabinoid.”

To view the full press release, visit

About Cannabis Global Inc.

Cannabis Global is a Nevada registered, fully reporting and audited publicly traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

CannabisNewsWire is part of the InvestorBrandNetwork.